A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Phase 3
Completed
- Conditions
- AIDSHIV InfectionsSmoking
- Registration Number
- NCT01106638
- Lead Sponsor
- Montefiore Medical Center
- Brief Summary
The purpose of this study is to determine whether an intensive, eight session behavioral intervention is superior to standard care in achieving abstinence from cigarettes in smokers living with HIV/AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 147
Inclusion Criteria
- HIV-infection
- current cigarette smoker
- high motivation to quit
Exclusion Criteria
- Pregnancy
- breastfeeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Three month point-prevalence abstinence from cigarettes 3 months post-intervention
- Secondary Outcome Measures
Name Time Method Three month continuous abstinence from cigarettes Three months post-intervention
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie smoking cessation success in HIV-positive individuals with nicotine dependence?
How does an eight-session behavioral intervention compare to standard care in HIV-infected smokers' abstinence rates?
Are there specific biomarkers that predict response to intensive smoking cessation therapies in PWHs?
What adverse events are associated with behavioral interventions for smoking cessation in immunocompromised patients?
What combination therapies show promise alongside behavioral interventions for HIV-related tobacco use disorders?
Trial Locations
- Locations (1)
Montefiore Medical Center
🇺🇸Bronx, New York, United States
Montefiore Medical Center🇺🇸Bronx, New York, United States